386 related articles for article (PubMed ID: 16091896)
41. Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report.
Charles PE; Kus E; Aho S; Prin S; Doise JM; Olsson NO; Blettery B; Quenot JP
BMC Infect Dis; 2009 Apr; 9():49. PubMed ID: 19386110
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic and prognostic value of procalcitonin in patients with septic shock.
Clec'h C; Ferriere F; Karoubi P; Fosse JP; Cupa M; Hoang P; Cohen Y
Crit Care Med; 2004 May; 32(5):1166-9. PubMed ID: 15190968
[TBL] [Abstract][Full Text] [Related]
43. [Relationship between procalcitonin serum levels and complications and outcome of patients with hematological malignancy admitted to Intensive Care Unit].
Ferrà C; Lacoma A; García O; Marcos P; Domínguez J; Ribera JM
Med Clin (Barc); 2012 Apr; 138(9):385-8. PubMed ID: 22257606
[TBL] [Abstract][Full Text] [Related]
44. Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial.
Müller F; Christ-Crain M; Bregenzer T; Krause M; Zimmerli W; Mueller B; Schuetz P;
Chest; 2010 Jul; 138(1):121-9. PubMed ID: 20299634
[TBL] [Abstract][Full Text] [Related]
45. Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever.
Chirouze C; Schuhmacher H; Rabaud C; Gil H; Khayat N; Estavoyer JM; May T; Hoen B
Clin Infect Dis; 2002 Jul; 35(2):156-61. PubMed ID: 12087521
[TBL] [Abstract][Full Text] [Related]
46. Serum procalcitonin level and SOFA score at discharge from the intensive care unit predict post-intensive care unit mortality: a prospective study.
Matsumura Y; Nakada TA; Abe R; Oshima T; Oda S
PLoS One; 2014; 9(12):e114007. PubMed ID: 25460569
[TBL] [Abstract][Full Text] [Related]
47. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock.
Brunkhorst FM; Wegscheider K; Forycki ZF; Brunkhorst R
Intensive Care Med; 2000 Mar; 26 Suppl 2():S148-52. PubMed ID: 18470710
[TBL] [Abstract][Full Text] [Related]
48. Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection.
Ingram PR; Inglis T; Moxon D; Speers D
Intensive Care Med; 2010 Mar; 36(3):528-32. PubMed ID: 20069274
[TBL] [Abstract][Full Text] [Related]
49. Old and new biomarkers for predicting high and low risk microbial infection in critically ill patients with new onset fever: a case for procalcitonin.
Hoeboer SH; Alberts E; van den Hul I; Tacx AN; Debets-Ossenkopp YJ; Groeneveld AB
J Infect; 2012 May; 64(5):484-93. PubMed ID: 22248983
[TBL] [Abstract][Full Text] [Related]
50. C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator-associated pneumonia.
Hillas G; Vassilakopoulos T; Plantza P; Rasidakis A; Bakakos P
Eur Respir J; 2010 Apr; 35(4):805-11. PubMed ID: 19717486
[TBL] [Abstract][Full Text] [Related]
51. Combination of biphasic transmittance waveform with blood procalcitonin levels for diagnosis of sepsis in acutely ill patients.
Zakariah AN; Cozzi SM; Van Nuffelen M; Clausi CM; Pradier O; Vincent JL
Crit Care Med; 2008 May; 36(5):1507-12. PubMed ID: 18434897
[TBL] [Abstract][Full Text] [Related]
52. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates.
Claeys R; Vinken S; Spapen H; ver Elst K; Decochez K; Huyghens L; Gorus FK
Crit Care Med; 2002 Apr; 30(4):757-62. PubMed ID: 11940741
[TBL] [Abstract][Full Text] [Related]
53. Usefulness of a semi-quantitative procalcitonin test and the A-DROP Japanese prognostic scale for predicting mortality among adults hospitalized with community-acquired pneumonia.
Kasamatsu Y; Yamaguchi T; Kawaguchi T; Tanaka N; Oka H; Nakamura T; Yamagami K; Yoshioka K; Imanishi M
Respirology; 2012 Feb; 17(2):330-6. PubMed ID: 22059525
[TBL] [Abstract][Full Text] [Related]
54. The value of procalcitonin level in community-acquired pneumonia in the ED.
Park JH; Wee JH; Choi SP; Oh SH
Am J Emerg Med; 2012 Sep; 30(7):1248-54. PubMed ID: 22030193
[TBL] [Abstract][Full Text] [Related]
55. Procalcitonin as an Early Marker of the Need for Invasive Respiratory or Vasopressor Support in Adults With Community-Acquired Pneumonia.
Self WH; Grijalva CG; Williams DJ; Woodworth A; Balk RA; Fakhran S; Zhu Y; Courtney DM; Chappell J; Anderson EJ; Qi C; Waterer GW; Trabue C; Bramley AM; Jain S; Edwards KM; Wunderink RG
Chest; 2016 Oct; 150(4):819-828. PubMed ID: 27107491
[TBL] [Abstract][Full Text] [Related]
56. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.
Shehabi Y; Sterba M; Garrett PM; Rachakonda KS; Stephens D; Harrigan P; Walker A; Bailey MJ; Johnson B; Millis D; Ding G; Peake S; Wong H; Thomas J; Smith K; Forbes L; Hardie M; Micallef S; Fraser JF; ;
Am J Respir Crit Care Med; 2014 Nov; 190(10):1102-10. PubMed ID: 25295709
[TBL] [Abstract][Full Text] [Related]
57. [Procalcitonin change pattern in patients with septic shock and its relationship with prognosis].
Huang WP; Huang C; Wen MY; Jiang WQ; Zeng HK
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Aug; 25(8):467-70. PubMed ID: 24021041
[TBL] [Abstract][Full Text] [Related]
58. Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients.
Charles PE; Dalle F; Aho S; Quenot JP; Doise JM; Aube H; Olsson NO; Blettery B
Intensive Care Med; 2006 Oct; 32(10):1577-83. PubMed ID: 16896850
[TBL] [Abstract][Full Text] [Related]
59. A composite score combining procalcitonin, C-reactive protein and temperature has a high positive predictive value for the diagnosis of intensive care-acquired infections.
Robriquet L; Séjourné C; Kipnis E; D'Herbomez M; Fourrier F
BMC Infect Dis; 2013 Apr; 13():159. PubMed ID: 23547830
[TBL] [Abstract][Full Text] [Related]
60. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
Sridharan P; Chamberlain RS
Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]